Experts highlight the importance of nanomedicine and bioengineering to address health challenges
Institutional news
This Sant Jordi comes with the first IBBI comic, the superheroine of Bioengineering
Coinciding with International Book Day and Sant Jordi, the Institute for Bioengineering of Catalonia (IBEC) launches the first IBBI comic strip, the first Bioengineering superhero. In this first adventure, IBBI will use its superpowers to generate kidney organoids. This character aims to bring closer bioengineering to the non-scientific public, in an understandable and fun way, one of the disciplines that will mark the medicine of the future.
We want to be like you: scientists!
On the International Women’s Day, the Primary School “CEIP San Rafael” in Cádiz organized a series of activities with the aim of making the role of women in science more visible. Focusing on the figure of Nuria Montserrat, researcher ICREA at IBEC, and under the motto: “Nuria Montserrat: a woman of the future… and of the present,” the students honoured this scientist and recognized the work that, like her, is done by many researchers in our country.
IBEC and the NEN Association join forces against childhood neuroblastoma
The association of “Families and Friends of Children with Neuroblastoma” (NEN) and IBEC sign a collaboration agreement to search for new therapeutic markers for this type of cancer, through the generation of models based on engineering techniques. The project will be led by Dr. Áranzazu Vilasante, IBEC researcher.
The Spanish Nanomedicine Platform coordinated by IBEC receives a new boost
The Spanish Nanomedicine Platform (Nanomed Spain) has renewed the “Aid to Technological and Innovation Platforms” for the period 2021-2022 granted by the Ministry of Science and Innovation. Josep Samitier, director of the Institute for Bioengineering of Catalonia, coordinates the Nanomed Spain platform since its foundation in 2005.
The new “la Caixa” Foundation – BIST Chemical Biology Programme launches a hub in Barcelona for the design of new drugs
The “la Caixa” Foundation and BIST are creating a chemical biology programme to promote two new cutting-edge research groups at IBEC and IRB (both centres are members of BIST). The initiative aims to attract talent from the field of chemical biology, and to create an ecosystem that fosters research excellence in improving health.
IBEC alumni Alberto Elosegui-Artola, new scientific leader at the Francis Crick Institute
Alberto Elosegui-Artola, IBEC alumni and expert in mechanobiology, will start in a few days his own research group to study cell and tissue mechanics at the Francis Crick Institute, in a joint appointment with the Physics Department at King’s College London. This is another example of great success of IBEC alumni in the international scientific arena.
IBEC Group Leader Silvia Muro, elected to join the American medical and biological engineering elite
The American Institute for Medical and Biological Engineering (AIMBE) has announced the election of Dr. Silvia Muro as a member of the college of Fellows for her achievements on the behavior of nanomedicines at the cellular and molecular levels.
Nanomedicine against rare diseases joins forces
Nano Rare Diseases Day is an event organized for February 24th within the framework of the World Day for Minority Diseases, in which will be known the latest innovations in the field of Nanomedicine for the treatment and diagnosis of these diseases also known as rare or orphan.
Marino Arroyo, associated researcher at IBEC, honoured with an ICREA Academia award
